Bausch Health Co. Inc. (BHC) Posts Q4 Adjusted EBITDA of $898 Million, Revs Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Cowen Defends Bausch Health Companies (BHC); 'Add Here'
February 19, 2020 11:37 AM ESTCowen analyst Ken Cacciatore reiterated an Outperform rating and $40.00 price target on Bausch Health Companies (NYSE: BHC), saying there is no change to the thesis and investors should add here.
The analyst commented, "Q4 revs were slightly above the Street, while earnings... More
Guggenheim Says Bausch Health Companies (BHC) Sell-Off 'Overdone'
February 19, 2020 11:17 AM ESTGuggenheim analyst Dana Flanders came out to defend Bausch Health Companies (NYSE: BHC), saying the sell-off is overdone.
incremental updates unlikely to inspire near-term confidence, but sell-off overdone.The analyst reiterated a Buy rating and $36.00 price target on... More
